Medical and health physicists play important roles at the intersection of radiobiology, radioepidemiology, and safety. Radiobiology concepts are foundational for understanding dose-response relationships, therapeutic ratio, and the exploration of hypofractionation and ultra-hypofractionation. Ongoing radioepidemiology studies of both primary and secondary outcomes help to provide assessments of such advanced techniques. At the same time, health care providers and institutions continue to concentrate resources on improving quality treatment delivery while reducing errors that impact the safety and well-being of patients. Technological advancements, more complex, and more precise treatments challenge the industry to deliver such life-saving treatments both safely and effectively. Jean St. Germain presided at the crossroads of these areas for over 50 y, with contributions to the field of medical and health physics that were vast and significant. She served AAPM as National Secretary, Chair of the Rules Committee, Parliamentarian, founding Chair of the Development Committee, Member of the Governing Board of the AIP, Treasurer of the American Academy of Health Physics, Chair of the Examining Panel in Medical Health Physics and Viceâ€?Chair of the American Board of Medical Physics. She also served four terms on the AAPM Board of Directors. In the Greater New York area, she served as the President of the Radiological and Medical Physics Society (RAMPS, the NYC Chapter of the AAPM). In 2015, Jean was presented with the Marvin M. D. Williams Professional Achievement Award. This session is dedicated to her memory and provides important updates in radiobiology, radioepidemiology, and safety.
1. Describe key biological effects for a therapy program that includes hypofractionation treatment.
2. Summarize the key findings to date from the WECARE breast cancer epidemiology study.
3. Describe the strengths and opportunities for improvement associated with current radiotherapy error prevention processes.